Alnylam Pharma (ALNY) Tops Q2 EPS by 30c
Tweet
Share
E-mail
Get Alerts ALNY Hot Sheet
Price: $224.60 -1.77%
Financial Fact:
Net loss per common share - basic and diluted: -1.05
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Net loss per common share - basic and diluted: -1.05
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Alnylam Pharma (NASDAQ: ALNY) reported Q2 EPS of ($1.30), $0.30 better than the analyst estimate of ($1.60). Revenue for the quarter came in at $220.1 million versus the consensus estimate of $193.18 million.
For earnings history and earnings-related data on Alnylam Pharma (ALNY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
